Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pan-TGFβ inhibition by SAR439459 relieves immunosuppression and improves antitumor efficacy of PD-1 blockade.
Greco R, Qu H, Qu H, Theilhaber J, Shapiro G, Gregory R, Winter C, Malkova N, Sun F, Jaworski J, Best A, Pao L, Hebert A, Levit M, Protopopov A, Pollard J, Bahjat K, Wiederschain D, Sharma S. Greco R, et al. Among authors: theilhaber j. Oncoimmunology. 2020 Sep 13;9(1):1811605. doi: 10.1080/2162402X.2020.1811605. Oncoimmunology. 2020. PMID: 33224628 Free PMC article.
Isatuximab Acts Through Fc-Dependent, Independent, and Direct Pathways to Kill Multiple Myeloma Cells.
Zhu C, Song Z, Wang A, Srinivasan S, Yang G, Greco R, Theilhaber J, Shehu E, Wu L, Yang ZY, Passe-Coutrin W, Fournier A, Tai YT, Anderson KC, Wiederschain D, Bahjat K, Adrián FJ, Chiron M. Zhu C, et al. Among authors: theilhaber j. Front Immunol. 2020 Aug 14;11:1771. doi: 10.3389/fimmu.2020.01771. eCollection 2020. Front Immunol. 2020. PMID: 32922390 Free PMC article.
Utility of the RIG-I Agonist Triphosphate RNA for Melanoma Therapy.
Helms MW, Jahn-Hofmann K, Gnerlich F, Metz-Weidmann C, Braun M, Dietert G, Scherer P, Grandien K, Theilhaber J, Cao H, Wagenaar TR, Schnurr MM, Endres S, Wiederschain D, Scheidler S, Rothenfußer S, Brunner B, König LM. Helms MW, et al. Among authors: theilhaber j. Mol Cancer Ther. 2019 Dec;18(12):2343-2356. doi: 10.1158/1535-7163.MCT-18-1262. Epub 2019 Sep 12. Mol Cancer Ther. 2019. PMID: 31515294
An integrative approach of digital image analysis and transcriptome profiling to explore potential predictive biomarkers for TGFβ blockade therapy.
Pomponio R, Tang Q, Mei A, Caron A, Coulibaly B, Theilhaber J, Rogers-Grazado M, Sanicola-Nadel M, Naimi S, Olfati-Saber R, Combeau C, Pollard J, Lin TT, Wang R. Pomponio R, et al. Among authors: theilhaber j. Acta Pharm Sin B. 2022 Sep;12(9):3594-3601. doi: 10.1016/j.apsb.2022.03.013. Epub 2022 Mar 25. Acta Pharm Sin B. 2022. PMID: 36176910 Free PMC article.
GECKO: a complete large-scale gene expression analysis platform.
Theilhaber J, Ulyanov A, Malanthara A, Cole J, Xu D, Nahf R, Heuer M, Brockel C, Bushnell S. Theilhaber J, et al. BMC Bioinformatics. 2004 Dec 10;5:195. doi: 10.1186/1471-2105-5-195. BMC Bioinformatics. 2004. PMID: 15588317 Free PMC article.
Identification of a molecular signature of sarcopenia.
Giresi PG, Stevenson EJ, Theilhaber J, Koncarevic A, Parkington J, Fielding RA, Kandarian SC. Giresi PG, et al. Among authors: theilhaber j. Physiol Genomics. 2005 Apr 14;21(2):253-63. doi: 10.1152/physiolgenomics.00249.2004. Epub 2005 Feb 1. Physiol Genomics. 2005. PMID: 15687482 Free article.
14 results